Dysregulated miR-34a-SIRT1-Acetyl p65 axis is a potential mediator of immune activation in the colon during chronic simian immunodeficiency virus infection of rhesus macaques

Journal of Immunology

Volumn 194, Issue 1, 2015, Pages 291-306

  Mohan, Mahesh ^a   Kumar, Vinay ^a   Lackner, Andrew A ^a   Alvarez, Xavier ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTONE GAMMAH2AX; HISTONE H2AX; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; LYSINE; MICRORNA 34A; SIRTUIN 1; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; HISTONE; MICRORNA; TRANSCRIPTION FACTOR RELA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4 LYMPHOCYTE COUNT; CELLULAR DISTRIBUTION; COLON; COLON MUCOSA; CONTROLLED STUDY; CRYPT CELL; DISEASE COURSE; DNA DAMAGE; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; IMMUNOREGULATION; IMMUNOSTIMULATION; LAMINA PROPRIA; LEUKOCYTE; LUCIFERASE ASSAY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PLASMA CELL; PROTEIN ACETYLATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TISSUE DISTRIBUTION; UPREGULATION; VIRUS LOAD; ACETYLATION; ANIMAL; BIOSYNTHESIS; DNA REPAIR; GENETICS; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; METABOLISM; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION INITIATION; VIROLOGY;

ACETYLATION; ANIMALS; CD4 LYMPHOCYTE COUNT; COLON; DNA DAMAGE; DNA REPAIR; HISTONES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLAMMATION; INTESTINAL MUCOSA; MACACA MULATTA; MICRORNAS; PLASMA CELLS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SIRTUIN 1; TRANSCRIPTION FACTOR RELA; TRANSCRIPTIONAL ACTIVATION; VIRAL LOAD;

EID: 84919665273     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401447     Document Type: Article

References (64)

1. Veazey, R. S., M. DeMaria, L. V. Chalifoux, D. E. Shvetz, D. R. Pauley, H. L. Knight, M. Rosenzweig, R. P. Johnson, R. C. Desrosiers, and A. A. Lackner. 1998. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280: 427-431.
2. Smit-McBride, Z., J. J. Mattapallil, M. McChesney, D. Ferrick, and S. Dandekar. 1998. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4+ T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J. Virol. 72: 6646-6656.
3. Mattapallil, J. J., D. C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer. 2005. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
4. Brenchley, J. M., T. W. Schacker, L. E. Ruff, D. A. Price, J. H. Taylor, G. J. Beilman, P. L. Nguyen, A. Khoruts, M. Larson, A. T. Haase, and D. C. Douek. 2004. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200: 749-759.
5. Mehandru, S., M. A. Poles, K. Tenner-Racz, A. Horowitz, A. Hurley, C. Hogan, D. Boden, P. Racz, and M. Markowitz. 2004. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200: 761-770.
6. MacArthur, R. D., and H. L. DuPont. 2012. Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era. Clin. Infect. Dis. 55: 860-867.
7. Klatt, N. R., N. T. Funderburg, and J. M. Brenchley. 2013. Microbial translocation, immune activation, and HIV disease. Trends Microbiol. 21: 6-13.
8. Marchetti, G., C. Tincati, and G. Silvestri. 2013. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin. Microbiol. Rev. 26: 2-18.
9. McGowan, I., J. Elliott, M. Fuerst, P. Taing, J. Boscardin, M. Poles, and P. Anton. 2004. Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J. Acquir. Immune Defic. Syndr. 37: 1228-1236.
10. Mohan, M., P. P. Aye, J. T. Borda, X. Alvarez, and A. A. Lackner. 2007. Gastrointestinal disease in simian immunodeficiency virus-infected rhesus macaques is characterized by proinflammatory dysregulation of the interleukin-6-Janus kinase/signal transducer and activator of transcription3 pathway. Am. J. Pathol. 171: 1952-1965.
11. George, M. D., S. Sankaran, E. Reay, A. C. Gelli, and S. Dandekar. 2003. Highthroughput gene expression profiling indicates dysregulation of intestinal cell cycle mediators and growth factors during primary simian immunodeficiency virus infection. Virology 312: 84-94.
12. Sankaran, S., M. D. George, E. Reay, M. Guadalupe, J. Flamm, T. Prindiville, and S. Dandekar. 2008. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J. Virol. 82: 538-545.
13. Mohan, M., D. Kaushal, P. P. Aye, X. Alvarez, R. S. Veazey, and A. A. Lackner. 2012. Focused examination of the intestinal lamina propria yields greater molecular insight into mechanisms underlying SIV induced immune dysfunction. PLoS ONE 7: E34561.
14. Mohan, M., D. Kaushal, P. P. Aye, X. Alvarez, R. S. Veazey, and A. A. Lackner. 2013. Focused examination of the intestinal epithelium reveals transcriptional signatures consistent with disturbances in enterocyte maturation and differentiation during the course of SIV infection. PLoS ONE 8: E60122.
15. Ambros, V. 2004. The functions of animal microRNAs. Nature 431: 350-355.
16. Swaminathan, S., D. D. Murray, and A. D. Kelleher. 2013. miRNAs and HIV: Unforeseen determinants of host-pathogen interaction. Immunol. Rev. 254: 265-280.
17. Triboulet, R., B. Mari, Y. L. Lin, C. Chable-Bessia, Y. Bennasser, K. Lebrigand, B. Cardinaud, T. Maurin, P. Barbry, V. Baillat, et al. 2007. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315: 1579-1582.
18. Witwer, K. W., S. L. Sarbanes, J. Liu, and J. E. Clements. 2011. A plasma microRNA signature of acute lentiviral infection: Biomarkers of central nervous system disease. AIDS 25: 2057-2067.
19. Yelamanchili, S. V., A. D. Chaudhuri, L. N. Chen, H. Xiong, and H. S. Fox. 2010. MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease. Cell Death Dis. 1: E77.
20. Sisk, J. M., K. W. Witwer, P. M. Tarwater, and J. E. Clements. 2013. SIV replication is directly downregulated by four antiviral miRNAs. Retrovirology 10: 95.
21. Mohan, M., L. C. Chandra, W. Torben, P. P. Aye, X. Alvarez, and A. A. Lackner. 2014. miR-190b is markedly upregulated in the intestine in response to SIV replication and partly regulates myotubularin related protein-6 expression. J. Immunol. 193: 1301-1313.
22. Chen, F., and S. J. Hu. 2012. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: A review. J. Biochem. Mol. Toxicol. 26: 79-86.
23. Bai, X. Y., Y. Ma, R. Ding, B. Fu, S. Shi, and X. M. Chen. 2011. miR-335 and miR-34a promote renal senescence by suppressing mitochondrial antioxidative enzymes. J. Am. Soc. Nephrol. 22: 1252-1261.
24. Qin, B., H. Yang, and B. Xiao. 2012. Role of microRNAs in endothelial inflammation and senescence. Mol. Biol. Rep. 39: 4509-4518.
25. Mestdagh, P., P. Van Vlierberghe, A. De Weer, D. Muth, F. Westermann, F. Speleman, and J. Vandesompele. 2009. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 10: R64.
26. D'haene, B., P. Mestdagh, J. Hellemans, and J. Vandesompele. 2012. miRNA expression profiling: From reference genes to global mean normalization. Methods Mol. Biol. 822: 261-272.
27. Rippo, M. R., F. Olivieri, V. Monsurro, F. Prattichizzo, M. C. Albertini, and A. D. Procopio. 2014. MitomiRs in human inflamm-Aging: A hypothesis involving miR-181a, miR-34a and miR-146a. Exp. Gerontol. 56: 154-163.
28. Rudolf, E., S. John, and M. Cervinka. 2012. Irinotecan induces senescence and apoptosis in colonic cells in vitro. Toxicol. Lett. 214: 1-8.
29. Pan, D., A. Das, D. Liu, R. S. Veazey, and B. Pahar. 2012. Isolation and characterization of intestinal epithelial cells from normal and SIV-infected rhesus macaques. PLoS ONE 7: E30247.
30. Kato, M., T. Paranjape, R. U. Muller, S. Nallur, E. Gillespie, K. Keane, A. Esquela-Kerscher, J. B. Weidhaas, and F. J. Slack. 2009. The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 28: 2419-2424.
31. Hu, H., and R. A. Gatti. 2011. MicroRNAs: New players in the DNA damage response. J. Mol. Cell Biol. 3: 151-158.
32. Lawless, C., C. Wang, D. Jurk, A. Merz, Tv. Zglinicki, and J. F. Passos. 2010. Quantitative assessment of markers for cell senescence. Exp. Gerontol. 45: 772-778.
33. Wang, C., D. Jurk, M. Maddick, G. Nelson, C. Martin-Ruiz, and T. Von Zglinicki. 2009. DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 8: 311-323.
34. Yamakuchi, M., M. Ferlito, and C. J. Lowenstein. 2008. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. USA 105: 13421-13426.
35. Kauppinen, A., T. Suuronen, J. Ojala, K. Kaarniranta, and A. Salminen. 2013. Antagonistic crosstalk between NF-kB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell. Signal. 25: 1939-1948.
36. Risques, R. A., L. A. Lai, T. A. Brentnall, L. Li, Z. Feng, J. Gallaher, M. T. Mandelson, J. D. Potter, M. P. Bronner, and P. S. Rabinovitch. 2008. Ulcerative colitis is a disease of accelerated colon aging: Evidence from telomere attrition and DNA damage. Gastroenterology 135: 410-418.
37. Singh, U. P., N. P. Singh, B. Singh, L. J. Hofseth, R. L. Price, M. Nagarkatti, and P. S. Nagarkatti. 2010. Resveratrol (trans-3, 5, 49-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kB activation to abrogate dextran sulfate sodium-induced colitis. J. Pharmacol. Exp. Ther. 332: 829-839.
38. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
39. Guo, H., N. T. Ingolia, J. S. Weissman, and D. P. Bartel. 2010. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
40. Su, B. H., Y. L. Tseng, G. S. Shieh, Y. C. Chen, Y. C. Shiang, P. Wu, K. J. Li, T. H. Yen, A. L. Shiau, and C. L. Wu. 2013. Prothymosin a overexpression contributes to the development of pulmonary emphysema. Nat. Commun. 4: 1906.
41. O'Connell, R. M., D. S. Rao, and D. Baltimore. 2012. MicroRNA regulation of inflammatory responses. Annu. Rev. Immunol. 30: 295-312.
42. Artis, D. 2008. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8: 411-420.
43. Zhang, H. S., X. Y. Chen, T. C. Wu, W. W. Sang, and Z. Ruan. 2012. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFkB pathway. FEBS Lett. 586: 4203-4207.
44. Chang, J. R., R. Mukerjee, A. Bagashev, L. Del Valle, T. Chabrashvili, B. J. Hawkins, J. J. He, and B. E. Sawaya. 2011. HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. J. Biol. Chem. 286: 41125-41134.
45. Yu, Z., D. Fan, B. Gui, L. Shi, C. Xuan, L. Shan, Q. Wang, Y. Shang, and Y. Wang. 2012. Neurodegeneration-Associated TDP-43 interacts with fragile X mental retardation protein (FMRP)/Staufen (STAU1) and regulates SIRT1 expression in neuronal cells. J. Biol. Chem. 287: 22560-22572.
46. Chaudhuri, A. D., S. V. Yelamanchili, M. C. Marcondes, and H. S. Fox. 2013. Up-regulation of microRNA-142 in simian immunodeficiency virus encephalitis leads to repression of sirtuin1. FASEB J. 27: 3720-3729.
47. Chun, T. W., D. C. Nickle, J. S. Justement, J. H. Meyers, G. Roby, C. W. Hallahan, S. Kottilil, S. Moir, J. M. Mican, J. I. Mullins, et al. 2008. Persistence of HIV in gut-Associated lymphoid tissue despite long-term antiretroviral therapy. J. Infect. Dis. 197: 714-720.
48. Huang, B., X. D. Yang, A. Lamb, and L. F. Chen. 2010. Posttranslational modifications of NF-kB: Another layer of regulation for NF-kB signaling pathway. Cell. Signal. 22: 1282-1290.
49. Kwon, H. S., M. M. Brent, R. Getachew, P. Jayakumar, L. F. Chen, M. Schnolzer, M. W. McBurney, R. Marmorstein, W. C. Greene, and M. Ott. 2008. Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation. Cell Host Microbe 3: 158-167.
50. Barry, S. P., P. A. Townsend, R. A. Knight, T. M. Scarabelli, D. S. Latchman, and A. Stephanou. 2010. STAT3 modulates the DNA damage response pathway. Int. J. Exp. Pathol. 91: 506-514.
51. Li, S., H. F. Moffett, J. Lu, L. Werner, H. Zhang, J. Ritz, D. Neuberg, K. W. Wucherpfennig, J. R. Brown, and C. D. Novina. 2011. MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. PLoS ONE 6: E16956.
52. Miyazaki, Y., R. Li, A. Rezk, H. Misirliyan, C. Moore, N. Farooqi, M. Solis, L. G. Goiry, O. de Faria Junior, V. D. Dang, et al; CIHR/MSSC New Emerging Team Grant in Clinical Autoimmunity.; MSSRF Canadian B cells in MS Team. 2014. A novel microRNA-132-surtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis. PLoS ONE 9: E105421.
53. Nilssen, D. E., O. Oktedalen, and P. Brandtzaeg. 2004. Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy. Gut 53: 487-493.
54. Gordon, J. N., K. M. Pickard, A. Di Sabatino, J. D. Prothero, S. L. Pender, P. M. Goggin, and T. T. MacDonald. 2008. Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel disease. Inflamm. Bowel Dis. 14: 195-203.
55. Staudt, L. M. 2010. Oncogenic activation of NF-kB. Cold Spring Harb. Perspect. Biol. 2: A000109.
56. Li, J., K. Wang, X. Chen, H. Meng, M. Song, Y. Wang, X. Xu, and Y. Bai. 2012. Transcriptional activation of microRNA-34a by NF-kB in human esophageal cancer cells. BMC Mol. Biol. 13: 4.
57. Lefranc, G., and M. P. Lefranc. 1990. Regulation of the immunoglobulin gene transcription. Biochimie 72: 7-17.
58. Oltz, E. M. 2001. Regulation of antigen receptor gene assembly in lymphocytes. Immunol. Res. 23: 121-133.
59. Durandy, A. 2002. Hyper-IgM syndromes: A model for studying the regulation of class switch recombination and somatic hypermutation generation. Biochem. Soc. Trans. 30: 815-818.
60. Doi, T. S., T. Takahashi, O. Taguchi, T. Azuma, and Y. Obata. 1997. NF-kB RelA-deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185: 953-961.
61. Roman-Blas, J. A., and S. A. Jimenez. 2006. NF-kB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 14: 839-848.
62. Uo, M., T. Hisamatsu, J. Miyoshi, D. Kaito, K. Yoneno, M. T. Kitazume, M. Mori, A. Sugita, K. Koganei, K. Matsuoka, et al. 2013. Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcgR-mediated CD14 macrophage activation. Gut 62: 1734-1744.
63. Rao, D. S., R. M. O'Connell, A. A. Chaudhuri, Y. Garcia-Flores, T. L. Geiger, and D. Baltimore. 2010. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 33: 48-59.
64. Tomé-Carneiro, J., M. Larrosa, M. J. Yánez-Gascón, A. Dávalos, J. Gil- Zamorano, M. Gonzálvez, F. J. García-Almagro, J. A. Ruiz Ros, F. A. Tomás- Barberán, J. C. Espín, and M. T. García-Conesa. 2013. One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol. Res. 72: 69-82.